QCM
KALV

Quantinno Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History

Quantinno Capital Management’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$653K Buy
32,453
+3,297
+11% +$53.1K ﹤0.01% 2516
2025
Q4 		$471K Buy
29,156
+14,998
+106% +$199K ﹤0.01% 2493
2025
Q3 		$172K Buy
+14,158
New +$196K ﹤0.01% 2802

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Quantinno Capital Management's KALV Position: Q1 2026 in Review

Quantinno Capital Management increased its KalVista Pharmaceuticals (KALV) stake by 11% in Q1 2026, buying an estimated $53.1K and bringing the position to 32,453 shares worth $653K. The position accounts for ﹤0.01% of the portfolio, ranked #2516.

Quantinno Capital Management first reported a position in KALV in Q3 2025 and has held it in 3 quarters since. 183 funds tracked by Wall St. Rank hold KALV as of Q1 2026.

  • Quantinno Capital Management held 32,453 shares of KalVista Pharmaceuticals worth $653K as of Q1 2026.
  • Quantinno Capital Management bought 3,297 KalVista Pharmaceuticals shares in Q1 2026, an estimated $53.1K.
  • KalVista Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2516 holding.
  • Quantinno Capital Management first reported a position in KalVista Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 183 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.